However, ST6GalNAc6 may also enhance the metastatic capability of tumor cells, as silencing of ST6GalNAc6 in a renal cell carcinoma (RCC) cell line, expressing lower levels of DSGb5, exhibited decreased migration, but not proliferation, in vitro (192). Here, ST6GALNAC6 is linked to renal cell carcinoma.